These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36533294)

  • 1. Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.
    Farini A; Tripodi L; Villa C; Strati F; Facoetti A; Baselli G; Troisi J; Landolfi A; Lonati C; Molinaro D; Wintzinger M; Gatti S; Cassani B; Caprioli F; Facciotti F; Quattrocelli M; Torrente Y
    EMBO Mol Med; 2023 Mar; 15(3):e16244. PubMed ID: 36533294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
    Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
    Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice.
    De la Garza-Rodea AS; Moore SA; Zamora-Pineda J; Hoffman EP; Mistry K; Kumar A; Strober JB; Zhao P; Suh JH; Saba JD
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the Role of Gut Microbiota in Duchenne Muscular Dystrophy: An Age-Related Study in Mdx Mice.
    Jollet M; Mariadassou M; Rué O; Pessemesse L; Ollendorff V; Ramdani S; Vernus B; Bonnieu A; Bertrand-Gaday C; Goustard B; Koechlin-Ramonatxo C
    Am J Pathol; 2024 Feb; 194(2):264-279. PubMed ID: 37981219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy.
    Alves FM; Kysenius K; Caldow MK; Hardee JP; Chung JD; Trieu J; Hare DJ; Crouch PJ; Ayton S; Bush AI; Lynch GS; Koopman R
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1541-1553. PubMed ID: 35249268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral Micro-dystrophin Gene Treatment into Late-stage mdx Mice for Duchenne Muscular Dystrophy Disease.
    Eren SA; Tastan C; Karadeniz KB; Turan RD; Cakirsoy D; Kancagi DD; Yilmaz SU; Oztatlici M; Oztatlici H; Ozer S; Tumentemur G; Baykal AT; Ovali E
    Curr Gene Ther; 2023; 23(4):304-315. PubMed ID: 37032509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
    Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
    Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice.
    Gallot YS; Straughn AR; Bohnert KR; Xiong G; Hindi SM; Kumar A
    Hum Mol Genet; 2018 Oct; 27(19):3449-3463. PubMed ID: 30010933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A microtubule-connexin-43 regulatory link suppresses arrhythmias and cardiac fibrosis in Duchenne muscular dystrophy mice.
    Himelman E; Nouet J; Lillo MA; Chong A; Zhou D; Wehrens XHT; Rodney GG; Xie LH; Shirokova N; Contreras JE; Fraidenraich D
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H983-H995. PubMed ID: 36206047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative effects of dystrophin loss on metabolic function of the mdx mouse.
    Strakova J; Kamdar F; Kulhanek D; Razzoli M; Garry DJ; Ervasti JM; Bartolomucci A; Townsend D
    Sci Rep; 2018 Sep; 8(1):13624. PubMed ID: 30206270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
    Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
    Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
    Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
    J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbes, metabolites and muscle: Is the gut-muscle axis a plausible therapeutic target in Duchenne muscular dystrophy?
    Marullo AL; O'Halloran KD
    Exp Physiol; 2023 Sep; 108(9):1132-1143. PubMed ID: 37269541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrical impedance myography detects dystrophin-related muscle changes in mdx mice.
    Hiyoshi T; Zhao F; Baba R; Hirakawa T; Kuboki R; Suzuki K; Tomimatsu Y; O'Donnell P; Han S; Zach N; Nakashima M
    Skelet Muscle; 2023 Nov; 13(1):19. PubMed ID: 37980539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
    Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
    Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
    Wasala NB; Bostick B; Yue Y; Duan D
    Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.